Chemical Structure : T6I-29
Catalog No.: PC-22503Not For Human Use, Lab Use Only.
T6I-29 is a novel isoquinoline-based selective estrogen receptor modulator (SERM), interacts with Y537S ERα ligand binding domain (LBD), exhibits anti-proliferative activities, downregulates target genes, and elicits anti-tumoral activities.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
T6I-29 is a novel isoquinoline-based selective estrogen receptor modulator (SERM), interacts with Y537S ERα ligand binding domain (LBD), exhibits anti-proliferative activities, downregulates target genes, and elicits anti-tumoral activities.
T6I-29 demonstrates significant anti-proliferative activities in Y537S ERα breast cancer cells.
T6I-29 inhibits WT and Y537S ERα-Coactivator binding.
T6I-29 uniquely downregulates DKK1 in Y537S ESR1 breast cancer cells.
The active enantiomer of T6I-29, T6I-29-1A (25 mg/kg) inhibits tumor growth in ESR1 MCF7 Y537S xenograft model.
M.Wt | 514.64 | |
Formula | C32H35FN2O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Young KS, et al. bioRxiv [Preprint]. 2024 Jun 2:2024.05.28.596307.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright